Structure-guided optimisation of fenofibrate-derived oxidative phosphorylation inhibitors to modify tumour hypoxia. [PDF]
RSC Med ChemHolt-Martyn JP +10 more
europepmc +1 more source
Effects of PPARα, PPARγ, and dual PPARα/γ agonists on liver tissue and biochemical markers in NAFLD-induced Wistar rats. [PDF]
Res Pharm SciKhoshbakht E +4 more
europepmc +1 more source
PPARα activation alleviates lithocholic acid-induced liver injury by inhibiting pyroptosis. [PDF]
Liver ResLiang HF +9 more
europepmc +1 more source
Fenofibrate Mitigates Acute Lung Injury in a Rat Model of Feces-Induced Peritonitis. [PDF]
Int J Mol SciAkbaş A +8 more
europepmc +1 more source
Combining bioinformatics and machine learning to analyze and validate sepsis-related cell senescence genes and potential drugs. [PDF]
Ren FailPei S +9 more
europepmc +1 more source
Data Mining of the Japanese Adverse Drug Event Report Database and Animal Experiments for Assessment of Risks Associated With Pemafibrate. [PDF]
In VivoKobuchi S +11 more
europepmc +1 more source
Fenofibrate restores glutamatergic and dopaminergic homeostasis in the nucleus accumbens and reduces alcohol relapse in rats. [PDF]
Front PharmacolIsla E +8 more
europepmc +1 more source
Comparative efficacy and safety of ursodeoxycholic acid, fibrates, and combination therapy in primary biliary cholangitis: an umbrella meta-analysis of meta-analyses. [PDF]
Front PharmacolZhang J, Xiu T, Shen Q.
europepmc +1 more source
Clinical efficacy of combining fenofibrate with statins in patients with diabetes and hyperlipidemia: a meta-analysis. [PDF]
Front Endocrinol (Lausanne)Huang J, Meng K, Qiu H.
europepmc +1 more source
Plasma <sup>1</sup>H NMR-based metabolomic analysis reveals the lipid regulating effect of novel carboxamide derivatives in hyperlipidemic rats. [PDF]
MetabolomicsAlwahsh M +6 more
europepmc +1 more source